- Home
- AXSM vs AROC Comparison
AXSM vs AROC Comparison
Compare AXSM & AROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- AROC
- Stock Information
- Founded
- AXSM 2012
- AROC 1990
- Country
- AXSM United States
- AROC United States
- Employees
- AXSM N/A
- AROC N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- AROC Oil & Gas Production
- Sector
- AXSM Health Care
- AROC Energy
- Exchange
- AXSM Nasdaq
- AROC Nasdaq
- Market Cap
- AXSM 5.1B
- AROC 4.2B
- IPO Year
- AXSM 2015
- AROC 1997
- Fundamental
- Price
- AXSM $116.62
- AROC $23.83
- Analyst Decision
- AXSM Strong Buy
- AROC Buy
- Analyst Count
- AXSM 17
- AROC 6
- Target Price
- AXSM $175.76
- AROC $30.00
- AVG Volume (30 Days)
- AXSM 576.1K
- AROC 1.4M
- Earning Date
- AXSM 11-11-2025
- AROC 11-10-2025
- Dividend Yield
- AXSM N/A
- AROC 3.52%
- EPS Growth
- AXSM N/A
- AROC 49.93
- EPS
- AXSM N/A
- AROC 1.33
- Revenue
- AXSM $495,033,000.00
- AROC $1,348,892,000.00
- Revenue This Year
- AXSM $63.78
- AROC $31.31
- Revenue Next Year
- AXSM $55.74
- AROC $6.91
- P/E Ratio
- AXSM N/A
- AROC $17.95
- Revenue Growth
- AXSM 69.83
- AROC 28.23
- 52 Week Low
- AXSM $75.56
- AROC $19.65
- 52 Week High
- AXSM $139.13
- AROC $30.44
- Technical
- Relative Strength Index (RSI)
- AXSM 48.36
- AROC 44.73
- Support Level
- AXSM $112.90
- AROC $24.01
- Resistance Level
- AXSM $130.00
- AROC $24.89
- Average True Range (ATR)
- AXSM 3.70
- AROC 0.57
- MACD
- AXSM -1.47
- AROC -0.13
- Stochastic Oscillator
- AXSM 21.75
- AROC 10.78
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About AROC Archrock Inc.
Archrock Inc is an energy infrastructure company with a focus on midstream natural gas compression and a commitment to helping customers produce, compress, and transport natural gas. It has two business segments, Contract Operations, and Aftermarket Services. Under the umbrella of contract operations services, the company provides operations to meet customers' natural gas compression needs. Services include designing, owning, installing, operating, and maintaining equipment. Aftermarket Services business provides a full range of services to support the compression needs of customers who own compression equipment, including operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components. It generates maximum revenue from the Contract Operations segment.